作者: Nestor F. Gonzalez-Cadavid , Jacob A. Rajfer
DOI:
关键词: Disease 、 Genitourinary system 、 Ketamine 、 Dextromethorphan 、 NMDA receptor 、 Amantidine 、 Receptor 、 Medicine 、 Hyperplasia 、 Pharmacology
摘要: Methods are presented for the treatment of benign prostatic hyperplasia. The methods provide administration to a person at least one compound identified generically as antagonists N-methyl-D-aspartate receptors. These compounds selected from group consisting memantidine, amantidine, dextromethorphan and ketamine.